Microbicides are chemical agents used topically by women within the vagina in order to prevent infection by HIV and potentially by other enveloped viruses and sexually transmitted pathogens. Prototype microbicides are designed to be inserted prior to each act of sexual intercourse and could also be contraceptive, although most current potential microbicides are not. Several proof-of-principle phase III trials of candidate microbicides are currently in progress or are shortly to commence, and a definitive answer to their efficacy and safety is anticipated by 2008
The development of novel compounds to reduce the sexual transmission of human immunodeficiency virus...
Background With 2.5 million new HIV infections per year, effective preventive methods against HIV ar...
The reduction in human immunodeficiency virus (HIV) infection in women demonstrated by pericoital us...
Currently, there are an estimated 15,000 new infections that occur on a daily basis despite availabi...
BACKGROUND: With 2.5 million new HIV infections per year, effective preventive methods against HIV a...
Human immunodeficiency virus (HIV) is transmitted predominantly through sexual intercourse. Research...
he development of topical microbicides for HIV prevention originated in response to the unabated spr...
AbstractThere is an urgent need to develop vaginal microbicides to empower women to better control t...
Microbicides are products designed for vaginal or rectal use to prevent transmission of the human im...
Worldwide, HIV disproportionately affects women who are often unable to negotiate traditional HIV pr...
The majority of new HIV-1 infections are transmitted sexually by penetrating the mucosal barrier to ...
Research on the human-immunodeficiency virus (HIV) and HIV transmission prevention methods is extens...
As the human immunodeficiency virus and sexually transmitted disease epidemics advance relentlessly,...
SummaryIn 2007, nearly 7000 new cases of HIV infection occurred each day. There is a constant increa...
The HIV epidemic is, by many criteria, the worst outbreak of infectious disease in history. The rate...
The development of novel compounds to reduce the sexual transmission of human immunodeficiency virus...
Background With 2.5 million new HIV infections per year, effective preventive methods against HIV ar...
The reduction in human immunodeficiency virus (HIV) infection in women demonstrated by pericoital us...
Currently, there are an estimated 15,000 new infections that occur on a daily basis despite availabi...
BACKGROUND: With 2.5 million new HIV infections per year, effective preventive methods against HIV a...
Human immunodeficiency virus (HIV) is transmitted predominantly through sexual intercourse. Research...
he development of topical microbicides for HIV prevention originated in response to the unabated spr...
AbstractThere is an urgent need to develop vaginal microbicides to empower women to better control t...
Microbicides are products designed for vaginal or rectal use to prevent transmission of the human im...
Worldwide, HIV disproportionately affects women who are often unable to negotiate traditional HIV pr...
The majority of new HIV-1 infections are transmitted sexually by penetrating the mucosal barrier to ...
Research on the human-immunodeficiency virus (HIV) and HIV transmission prevention methods is extens...
As the human immunodeficiency virus and sexually transmitted disease epidemics advance relentlessly,...
SummaryIn 2007, nearly 7000 new cases of HIV infection occurred each day. There is a constant increa...
The HIV epidemic is, by many criteria, the worst outbreak of infectious disease in history. The rate...
The development of novel compounds to reduce the sexual transmission of human immunodeficiency virus...
Background With 2.5 million new HIV infections per year, effective preventive methods against HIV ar...
The reduction in human immunodeficiency virus (HIV) infection in women demonstrated by pericoital us...